$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How many months do you usually take Dramani/Delba? treatment cycle
2026-02-01 22:25:32
Check Details
Which one is more effective, Deflazacort or Prednisone?
2026-02-01 22:25:32
Check Details
Future development trends of Cabozantinib: from clinical application to new drug exploration
2026-02-01 22:25:32
Check Details
Is platinib (Pujihua) an injection or an oral medicine and how to use it?
2026-02-01 22:25:32
Check Details
Capmatinib (Touradida) prolongs survival in patients with advanced lung cancer
2026-02-01 22:25:32
Check Details
Sotorasib (AMG 510) indication scope and analysis of patients with KRAS mutations
2026-02-01 22:25:32
Check Details
Introduction to the grading standards and corresponding treatment methods for adverse reactions of adagrasib (Krazati)
2026-02-01 22:25:32
Check Details
How to correctly store larotrectinib (Vitaca) and its storage temperature requirements
2026-02-01 22:25:32
Check Details
How to delay Selinisol (Silvio) resistance and prolong its efficacy
2026-02-01 22:25:32
Check Details
Onset time and efficacy evaluation of Vigabatrin (Okeda) in the treatment of epilepsy
2026-02-01 22:25:32
Check Details
Analysis on how to adjust the medication regimen after complete drug resistance to Mobosetinib (Anvili)
2026-02-01 22:25:32
Check Details
Skin care and side effects prevention methods during Tepotinib (Tuodekang) treatment
2026-02-01 22:25:32
Check Details
1
2
...
2009
2010
2011
2012
2013
2014
2015
...
10226
10227
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Sabril (Vigabatrin) Explained: Indications, Vision Loss Risk & Key Warnings
2
FDA Approves Tauklarify for Tau PET Imaging in Alzheimer's Disease Assessment
3
First CELMoD Drug Zenbexus Wins FDA Accelerated Approval for Multiple Myeloma
4
Elamipretide Side Effects and Medication Safety Guide: Injection Site Reactions and Storage Essentials
5
Dutasteride Soft Capsules: Comprehensive Side Effect Profile and Management Strategies
6
Oral Semaglutide Tablets: A Complete Guide to the GLP-1 Receptor Agonist for Type 2 Diabetes and Cardiovascular Protection
7
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
8
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
9
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
10
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
11
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML
12
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights